CAS 53772-83-1: Zuclopenthixol
Formula:C22H25ClN2OS
InChI:InChI=1S/C22H25ClN2OS/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26/h1-2,4-8,16,26H,3,9-15H2/b18-5-
InChI key:InChIKey=WFPIAZLQTJBIFN-DVZOWYKESA-N
SMILES:C(\CCN1CCN(CCO)CC1)=C/2\C=3C(SC=4C2=CC=CC4)=CC=C(Cl)C3
Synonyms:- (Z)-Clopenthixol
- 1-Piperazineethanol, 4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-, (Z)-
- 4-[(3Z)-3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazineethanol
- 9H-Thioxanthene, 1-piperazineethanol deriv.
- Acuphase
- Cisordinol
- Clopixol
- Clopixol depo
- Zuclopenthixol
- cis-(Z)-Clopenthixol
- cis-Clopenthixol
- See more synonyms
Sort by
Found 12 products.
Zuclopenthixol
CAS:Zuclopenthixol (cis-Clopenthixol) is a thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics.Formula:C22H25ClN2OSPurity:98.90% - 99.82%Color and Shape:SolidMolecular weight:400.96Zuclopenthixol (-)-10-Camphorsulfonic Acid Salt
CAS:Controlled ProductApplications The labelled cis(Z)-form of Clopenthixol. Thioxanthene neuroleptic. Antipsychotic. References Sabbe, B., et al.: J. Psychiatr. Res., 30, 295 (1996), Riley, E., et al.: Schizophr. Res., 43, 47 (2000), Green, M., et al.: Biol. Psychiatry., 51, 972 (2002), Morrens, M., et al.: J. Clin. Psychopharmacol., 27, 15 (2007),Formula:C32H41ClN2O5S2Color and Shape:NeatMolecular weight:633.26Zuclopenthixol-d4 (-)-10-Camphorsulfonic Acid Salt
CAS:Controlled ProductApplications The labelled cis(Z)-form of Clopenthixol. Thioxanthene neuroleptic. Antipsychotic. References Sabbe, B., et al.: J. Psychiatr. Res., 30, 295 (1996), Riley, E., et al.: Schizophr. Res., 43, 47 (2000), Green, M., et al.: Biol. Psychiatry., 51, 972 (2002), Morrens, M., et al.: J. Clin. Psychopharmacol., 27, 15 (2007),Formula:C22D4H21ClN2OS·C10H15O4S·HColor and Shape:Light YellowMolecular weight:637.28Zuclopenthixol
CAS:Controlled ProductZuclopenthixol is a typical antipsychotic drug that is used to treat schizophrenia, bipolar disorder, and depression. It binds to dopamine D2 receptors in the brain to prevent them from being stimulated by dopamine. Zuclopenthixol also inhibits the synthesis of prolactin in the pituitary gland, which can cause side effects such as breast enlargement in males and females. The serum prolactin levels are measured using an analytical method such as radioimmunoassay or enzyme-linked immunosorbent assay. In addition, zuclopenthixol may increase the risk of infection due to its ability to lower the body's resistance to bacteria and viruses. It has been shown that zuclopenthixol has a high affinity for CB2 receptors (a type of cannabinoid receptor) which may be responsible for its anti-inflammatory activity.Formula:C22H25ClN2OSPurity:Min. 95%Molecular weight:400.96 g/molRef: 3D-DCA77283
Discontinued productZuclopenthixol
CAS:Controlled ProductFormula:C22H25ClN2OSColor and Shape:White To Light YellowMolecular weight:400.96Zuclopenthixol (1.0 Mg/Ml In Methanol)
CAS:Formula:C22H25ClN2OSColor and Shape:Single SolutionMolecular weight:400.96
